Show simple item record

dc.contributor.authorSibley, Carol Hopkinsen_US
dc.contributor.authorBarnes, Karen I.en_US
dc.contributor.authorPlowe, Christopher V.en_US
dc.date.accessioned2010-05-06T20:05:49Z
dc.date.available2010-05-06T20:05:49Z
dc.date.issued2007en_US
dc.identifier.citationSibley C, Barnes K, Plowe C. The rationale and plan for creating a World Antimalarial Resistance Network (WARN). Malaria Journal. 2007;6(1):118.en_US
dc.identifier.other10.1186/1475-2875-6-118en_US
dc.identifier.urihttp://www.malariajournal.com/content/6/1/118en_US
dc.identifier.urihttp://hdl.handle.net/1773/15842
dc.description.abstractDrug resistant malaria was a major factor contributing to the failure of a worldwide campaign to eradicate malaria in the last century, and now threatens the large investment being made by the global community in the rollout of effective new drug combinations to replace failed drugs. Four related papers in this issue of Malaria Journal make the case for creating the World Antimalarial Resistance Network (WARN), which will consist of four linked open-access global databases containing clinical, in vitro, molecular and pharmacological data, and networks of reference laboratories that will support these databases and related surveillance activities. WARN will serve as a public resource to guide antimalarial drug treatment and prevention policies and to help confirm and characterize the new emergence of new resistance to antimalarial drugs and to contain its spread.en_US
dc.description.sponsorshipThe meeting that gave rise to this paper was funded by a grant from the Bill and Melinda Gates Foundation.en_US
dc.language.isoen_USen_US
dc.titleThe rationale and plan for creating a World Antimalarial Resistance Network (WARN)en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record